The Covid-19 pandemic laid the foundation for the commercialization of the mRNA platform which pharmaceutical companies are now investing heavily. Not to be left out of the action, Sanofi also announced its new Translational Science Hub in Australia in December which will link to its mRNA Centre of
As one of the largest investors in research and development, Roche Diagnostics revealed plans to tackle tuberculosis (TB) which remains a pressing issue for the Asian region. The diagnostic giant also recently joined forces with the Korea Health Industry Development Institute (KHIDI) to cooperate on
Many might be surprised to learn that companies like Uber were once small start-ups. Similarly, in the medical space, technology-driven healthcare solutions have seen rapid growth with the explosion of artificial intelligence (AI) boosting the success of Korean companies like VUNO, Lunit, and 3billi
Asia-Pacific (APAC) medical and pharmaceutical fields have increased their presence globally in recent years. Such exponential growth has made the region one of the major players in the world, with various global pharmaceutical companies targeting the area as their future growth engine. Against this
